Search Clinical Trials
596,361 trials
ID
Status
Phase
Title
Sponsor
NCT07740668
Efficacy of Transcutaneous Electrical Stimulation Therapy in the Treatment of Overactive Bladder Developing After StrokeKutahya Health Sciences UniversityNot Yet RecruitingNot Applicable
NCT07740668Not Yet Recruiting
Not Applicable
Efficacy of Transcutaneous Electrical Stimulation Therapy in the Treatment of Ov...Kutahya Health Sciences U...
NCT07739680
EFFECTS OF HIPPOTHERAPY IN CHILDREN WITH CEREBRAL PALSYFenerbahce UniversityNot Yet RecruitingNot Applicable
NCT07739680Not Yet Recruiting
Not Applicable
EFFECTS OF HIPPOTHERAPY IN CHILDREN WITH CEREBRAL PALSYFenerbahce University
NCT07740031
Development of a Frailty Risk Prediction Model and Preliminary Evaluation of a Risk-stratified Social Robot-assisted Intervention in Middle-aged and Older Spousal CaregiversThe Hong Kong Polytechnic UniversityNot Yet RecruitingNot Applicable
NCT07740031Not Yet Recruiting
Not Applicable
Development of a Frailty Risk Prediction Model and Preliminary Evaluation of a R...The Hong Kong Polytechnic...
NCT07739420
A Randomized, Assessor-Blinded, Intraindividual Study on the Efficacy of Fractional Carbon Dioxide Laser Versus Long-Pulsed 1064 nm Nd:YAG Laser in the Treatment of Keratosis PilarisJose R. Reyes Memorial Medical CenterCompletedNot Applicable
NCT07739420Completed
Not Applicable
A Randomized, Assessor-Blinded, Intraindividual Study on the Efficacy of Fractio...Jose R. Reyes Memorial Me...
NCT07738133
Mechanisms Underlying Late-Life Prolonged Grief DisorderMedical College of WisconsinNot Yet RecruitingNot Applicable
NCT07738133Not Yet Recruiting
Not Applicable
Mechanisms Underlying Late-Life Prolonged Grief DisorderMedical College of Wiscon...
NCT07740200
Validation of the Synovo Digital Disease Activity Score (DDAS) Against Physician-Performed DAS28/CDAI: A Non-Clinical, Non-Interventional, Non-Academic StudyAap Ka ClinicCompleted
NCT07740200Completed
—
Validation of the Synovo Digital Disease Activity Score (DDAS) Against Physician...Aap Ka Clinic
NCT07739719
SAFE (Self-Administration of Flumist to ImprovE Uptake: A Household-Based Cluster Randomized Trial)McMaster UniversityNot Yet RecruitingPhase 4
NCT07739719Not Yet Recruiting
Phase 4
SAFE (Self-Administration of Flumist to ImprovE Uptake: A Household-Based Cluste...McMaster University
NCT07739758
A Study of YL201 in Combination With Serplulimab in Participants With Treatment-naïve Extensive-stage Small Cell Lung CancerMediLink Therapeutics (Suzhou) Co., Ltd.Not Yet RecruitingPhase 3
NCT07739758Not Yet Recruiting
Phase 3
A Study of YL201 in Combination With Serplulimab in Participants With Treatment-...MediLink Therapeutics (Su...
NCT07739225
Patient-Centered Education After Hip Fracture SurgeryAssiut UniversityNot Yet RecruitingNot Applicable
NCT07739225Not Yet Recruiting
Not Applicable
Patient-Centered Education After Hip Fracture SurgeryAssiut University
NCT07738887
Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic Leukemia With TP53 AlterationsAbbVieNot Yet RecruitingPhase 2
NCT07738887Not Yet Recruiting
Phase 2
Epcoritamab Plus Venetoclax Plus Ibrutinib in Patients With Chronic Lymphocytic...AbbVie
NCT07739498
Posterior Resin Bite Turbos Effect on Maxillary Expansion Using a HYRAX Expander in Early AdolescentsMansoura UniversityRecruitingNot Applicable
NCT07739498Recruiting
Not Applicable
Posterior Resin Bite Turbos Effect on Maxillary Expansion Using a HYRAX Expander...Mansoura University
NCT07740356
Prevalence of Brief Suicidal Crisis in Psychiatric SettingsUniversity Hospital, Clermont-FerrandRecruiting
NCT07740356Recruiting
—
Prevalence of Brief Suicidal Crisis in Psychiatric SettingsUniversity Hospital, Cler...
NCT07739160
The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke PatientsBeijing Suncadia Pharmaceuticals Co., LtdNot Yet RecruitingPhase 2
NCT07739160Not Yet Recruiting
Phase 2
The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke PatientsBeijing Suncadia Pharmace...
NCT07739589
A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Ethinyl Estradiol (EE) Content of TWIRLA® (Levonorgestrel and Ethinyl Estradiol) Transdermal SystemAgile TherapeuticsCompletedPhase 4
NCT07739589Completed
Phase 4
A Postmarketing Open-Label Study to Assess Residual Levonorgestrel (LNG) and Eth...Agile Therapeutics
NCT07739186
A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 2
NCT07739186Not Yet Recruiting
Phase 2
A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody...Baili-Bio (Chengdu) Pharm...
NCT07740629
Does Use of a Pre-Procedure Educational Video for Urodynamic Testing Reduces Anxiety?Yair DaykanNot Yet RecruitingNot Applicable
NCT07740629Not Yet Recruiting
Not Applicable
Does Use of a Pre-Procedure Educational Video for Urodynamic Testing Reduces Anx...Yair Daykan
NCT07740395
Connecting Loved Ones to Support and Empowering RecoveryRhode Island HospitalRecruitingNot Applicable
NCT07740395Recruiting
Not Applicable
Connecting Loved Ones to Support and Empowering RecoveryRhode Island Hospital
NCT07739199
A Study Comparing BL-B01D1 in Combination With PD-1/VEGF Bispecific Antibody Versus Chemotherapy in Combination With PD-1/VEGF Bispecific Antibody in First-line Patients With Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer(PANKU-Lung05)Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 2
NCT07739199Not Yet Recruiting
Phase 2
A Study Comparing BL-B01D1 in Combination With PD-1/VEGF Bispecific Antibody Ver...Baili-Bio (Chengdu) Pharm...
NCT07739472
Mobile Application-Supported Education in Nursing StudentsMaltepe UniversityCompletedNot Applicable
NCT07739472Completed
Not Applicable
Mobile Application-Supported Education in Nursing StudentsMaltepe University
NCT07739888
Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral AnticoagulationNovartis PharmaceuticalsNot Yet RecruitingPhase 3
NCT07739888Not Yet Recruiting
Phase 3
Study to Evaluate the effIcacy and Safety of Abelacimab in High-risk Patients Wi...Novartis Pharmaceuticals
Result Breakdown
Not yet recruiting13 (65%)
Completed4 (20%)
Recruiting3 (15%)
not_applicable10 (50%)
Phase 24 (20%)
Not Specified2 (10%)
Phase 42 (10%)
Phase 32 (10%)